Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.

doi:10.1111/cas.14290

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.

Cancer science - 1 Feb 2020

Nagashima Takeshi, Yamaguchi Ken, Urakami Kenichi, Shimoda Yuji, Ohnami Sumiko, Ohshima Keiichi, Tanabe Tomoe, Naruoka Akane, Kamada Fukumi, Serizawa Masakuni, Hatakeyama Keiichi, Matsumura Kenya, Ohnami Shumpei, Maruyama Koji, Mochizuki Tohru, Kusuhara Masatoshi, Shiomi Akio, Ohde Yasuhisa, Terashima Masanori, Uesaka Katsuhiko, Onitsuka Tetsuro, Nishimura Seiichiro, Hirashima Yasuyuki, Hayashi Nakamasa, Kiyohara Yoshio, Tsubosa Yasuhiro, Katagiri Hirohisa, Niwakawa Masashi, Takahashi Kaoru, Kashiwagi Hiroya, Nakagawa Masahiro, Ishida Yuji, Sugino Takashi, Takahashi Mitsuru, Akiyama Yasuto

Abstract excerpt

This study aimed to establish the Japanese Cancer Genome Atlas (JCGA) using data from fresh frozen tumor tissues obtained from 5143 Japanese cancer patients, including those with colorectal cancer (31.6%), lung cancer (16.5%), gastric cancer (10.8%) and other cancers (41.1%). The results are part of a single-center study called "High-tech Omics-based Patient Evaluation" or "Project HOPE" conducted at the Shizuoka...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Databases, Factual

Share to Exome Sequencing

Share to Genomics

Share to Japan

Share to Oligonucleotide Array Sequence Analysis

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 31863614
DOI: 10.1111/cas.14290
PMCID: PMC7004528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.PMID 31863614Read ↗

Cancer genomic medicine in JapanSemantic proximity Read ↗

Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in JapanSemantic proximity Read ↗

Clinical Significance of Multi-Cancer Genome Profiling: Data from A Japan HospitalSemantic proximity Read ↗

Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases.Semantic proximity Read ↗

Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.Semantic proximity Read ↗

Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.Semantic proximity Read ↗

Landscape of somatic alterations in large-scale solid tumors from an Asian population.Semantic proximity Read ↗

A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study).Semantic proximity Read ↗

Landscape of somatic alterations in large-scale solid tumors from an Asian populationSemantic proximity Read ↗

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read ↗

Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity Read ↗

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.